LLY
$148.81
Eli Lilly
($1.00)
(.67%)
LLY
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $1.78
Revenue:  $5.88 Bil
Thursday
Oct 29
6:25 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LLY reports earnings?
Beat
Meet
Miss

Where is LLY's stock price going from here?
Up
Flat
Down
Stock chart of LLY
Analysts
Summary of analysts' recommendations for LLY
Score
Grade
Pivots
Resistance
$152.15
$150.90
$149.86

$148.61

Support
$147.57
$146.32
$145.28
Tweet
Growth
Description
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Peers
InterCeptBioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsJohnson & JohnsonZoetisUltragenyx PharmaceuticalBristol-Myers SquibbCatalentMerck & Co.